80 likes | 140 Views
The global tissue diagnostics market is valued at USD 3,202.5 Million in 2015 and expected to reach USD 4,471.1 Million by 2020 at a CAGR of 6.9% from 2015 to 2020.
E N D
MarketsandMarkets Presents Tissue Diagnostics Market Trends – North American and Asian Region to Offer Significant Growth Opportunities http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html
The report “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020”, report is planned for publication in December 2015.The report provides a detailed overview of the major drivers, restraints, and opportunities in the global tissue diagnostics market along with the estimates and forecasts of the revenue and market share analysis. Browse: 76 market data tables 96 figures 169 pages and in-depth TOC on “Tissue Diagnostics Market” Download The PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=1063949 The global tissue diagnostics market is valued at USD 3,202.5 Million in 2015 and expected to reach USD 4,471.1 Million by 2020, at a CAGR of 6.9% from 2015 to 2020. http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html
A major driver for the growth of the tissue diagnostics industry is the increasing prevalence of cancer. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market. Talk To Our Research Experts@ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=1063949 However, the high growth potential in emerging economies and the increased use of personalized medicine will provide new growth opportunities to players in the market. This report segments the global market based on product, technology, disease, and end user. On the basis of product, the market is segmented into instruments and consumables. In 2015, consumables are expected to account for the largest share of the global market, by product, due to their low cost and ease of use. http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html
On the basis of technology, the tissue diagnostics market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. In 2015, the immunohistochemistry segment is expected to account for the largest share of the global market. The technology is mainly driven by growth in the IVD (in vitro diagnostics) market. On the basis of diseases, the tissue diagnostics market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. In 2015, the breast cancer segment is expected to account for the largest share of the global market. The growth of this segment is driven by the increasing incidence of breast cancer. On the basis of end users the global biopreservation media & equipment market report is segmented into biobanks, gene banks, hospitals and other end users. http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html
On the basis of region, the tissue diagnostics market is segmented into Asia, Europe, North America, and the Rest of the World (RoW). In 2015, North America is expected to command the largest share of the global market. The major players in tissue diagnostics market include Abbott Laboratories (U.S.), Agilent Technologies (U.S.), BioGenex Laboratories (U.S.), Bio SB (U.S.), Cell Signaling Technology (U.S.), Danaher Corporation (U.S.), F. Hoffman-La Roche AG (Switzerland), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), and Sakura Finetek Japan Co. http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html
About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html
Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://www.marketsandmarkets.comhttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets